Here's why La Roche-Posay is pulling its Effaclar Duo Acne Spot Treatment from retail shelves. La Roche-Posay is a brand under the L'Oreal Group umbrella. A La Roche-Posay spokesperson confirmed ...

The products are being recalled by the FDA for possible "benzene contamination." Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Proactiv Skin Smoothing Exfoliator and La Roche-Posay Effaclar Duo Dual Action Acne Treatment. The full list and lot numbers was posted online Tuesday. “Even with daily use of these products for ...

Against all the odds, Roche's Genentech unit has won FDA approval for its clot-busting drug TNKase as a treatment for acute ischaemic stroke, after all but abandoning the project a couple of years ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) and Beam Therapeutics (BEAM – Research Report).

Bernstein analyst Justin Smith maintained a Buy rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF345.00. The company’s shares opened today at $351.40.

James D. Hoffman was appointed a director of Reliance in October 2019 and became chief executive officer in January 2019. From March 2016 until his promotion to president and chief executive ...

HealthDay News — The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Betty Ann Besch Solinger (1930–2022) wrote of her late husband, “David lived a full ninety years and never stopped being thrilled by seeing a work of art he thought was beautiful.

The Vienna Philharmonic returned to Southern California in fine form, conducted by Yannick Nezet-Seguin with Yefim Bronfman as soloist.